177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the public.

Nuklearmedizin · 2026 · PMC13046430 · PMID 41610875

Europe PMC DOI

hedged sentence

0.1240

closest p · 2.5× alpha

0.1240

boldest claim

The sentences

did not reach statistical significancep = 0.124not close (p > 0.1)

Only for Lutathera the difference did not reach statistical significance (p = 0.124).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.